81 related articles for article (PubMed ID: 21323487)
1. Early development evaluation of AZD2738, a substrate for the NK receptors.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Drug Dev Ind Pharm; 2011 Jun; 37(6):719-26. PubMed ID: 21323487
[TBL] [Abstract][Full Text] [Related]
2. Early development evaluation of AZD8081: a substrate for the NK receptors.
Sigfridsson K; Ahlqvist M; Carlsson A; Fridström A
Drug Dev Ind Pharm; 2011 Jun; 37(6):702-13. PubMed ID: 21417618
[TBL] [Abstract][Full Text] [Related]
3. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
4. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
Sigfridsson K; Lundqvist R; Ohlson K
Drug Dev Ind Pharm; 2012 Jan; 38(1):19-31. PubMed ID: 21707325
[TBL] [Abstract][Full Text] [Related]
5. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties.
Tsutsumi S; Iida M; Tada N; Kojima T; Ikeda Y; Moriwaki T; Higashi K; Moribe K; Yamamoto K
Int J Pharm; 2011 Dec; 421(2):230-6. PubMed ID: 21983091
[TBL] [Abstract][Full Text] [Related]
6. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
8. A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior.
Shevchenko A; Bimbo LM; Miroshnyk I; Haarala J; Jelínková K; Syrjänen K; van Veen B; Kiesvaara J; Santos HA; Yliruusi J
Int J Pharm; 2012 Oct; 436(1-2):403-9. PubMed ID: 22750429
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
[TBL] [Abstract][Full Text] [Related]
10. Impact of counterion on the chemical stability of crystalline salts of procaine.
Guerrieri P; Jarring K; Taylor LS
J Pharm Sci; 2010 Sep; 99(9):3719-30. PubMed ID: 19967781
[TBL] [Abstract][Full Text] [Related]
11. Preformulation investigation of some clopidogrel addition salts.
Zupančič V; Smrkolj M; Benkič P; Simonič I; Plevnik M; Ritlop G; Kristl A; Vrečer F
Acta Chim Slov; 2010 Jun; 57(2):376-85. PubMed ID: 24061734
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
13. In situ salt screening--a useful technique for discovery support and preformulation studies.
Tong WQ; Whitesell G
Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
[TBL] [Abstract][Full Text] [Related]
14. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
[TBL] [Abstract][Full Text] [Related]
17. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
Tarsa PB; Towler CS; Woollam G; Berghausen J
Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
[TBL] [Abstract][Full Text] [Related]
18. The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.
Milton N; Nail SL
Pharm Dev Technol; 1996 Oct; 1(3):269-77. PubMed ID: 9552309
[TBL] [Abstract][Full Text] [Related]
19. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
Sigfridsson K; Nilsson L; Ahlqvist M; Andersson T; Granath AK
Eur J Pharm Sci; 2017 Jun; 104():262-272. PubMed ID: 28366653
[TBL] [Abstract][Full Text] [Related]
20. Crystallization of a salt of a weak organic acid and base: solubility relations, supersaturation control and polymorphic behavior.
Jones HP; Davey RJ; Cox BG
J Phys Chem B; 2005 Mar; 109(11):5273-8. PubMed ID: 16863194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
